🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT04028219
Recruiting Observational

Transgender In Transition

NCT04028219 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2019-05-15
Last updated
2022-11-08

Condition(s) studied

Gender Incongruence

Investigational drug(s) / intervention(s)

Online surveys

Online surveys: Psychometric measures within 14 online surveys, which is one at each assessment point (before and 3, 6, 9, 12, 24, 36, 48, 60, 72, 84, 96, 108, 120 months after hormonal therapy).

Study summary

Prospective trial in gender dysphoric patients who undergo gender-affirming hormone therapy, aiming to investigate psychological, biological and behavioural consequences of hormonal therapy.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * diagnosis of gender incongruence (ICD-11) or gender dysphoria (DSM-5) * written informed consent following adequate oral and written Information * before gender-affirming hormonal treatment Exclusion Criteria: * pregnancy or breast-feeding

Primary outcome measure(s)

Trial sites (5)

FacilityCityRegionStatus
Universitätsklinikum Frankfurt Frankfurt am Main Hesse Not Yet Recruiting
University Medical Center Hamburg-Eppendorf Hamburg Germany Recruiting
Medical Center of the Ludwig-Maximilians-University of Munich Munich Germany Not Yet Recruiting
Universitätsspital Basel Basel Switzerland Not Yet Recruiting
UniversitätsSpital Zürich Zurich Switzerland Not Yet Recruiting

More Universitätsklinikum Hamburg-Eppendorf trials in Germany

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04028219 on ClinicalTrials.gov ↗ ← All trials in Germany